FineMark National Bank & Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-168
Closed -$5K 1335
2016
Q2
$5K Buy
168
+12
+8% +$375 ﹤0.01% 1068
2016
Q1
$5K Sell
156
-51
-25% -$1.41K ﹤0.01% 1033
2015
Q4
$6K Buy
207
+5
+2% +$142 ﹤0.01% 1014
2015
Q3
$6K Hold
202
﹤0.01% 1062
2015
Q2
$7K Buy
202
+154
+321% +$5.49K ﹤0.01% 1058
2015
Q1
$2K Sell
48
-10
-17% -$342 ﹤0.01% 1243
2014
Q4
$2K Buy
+58
New +$1.81K ﹤0.01% 1262
2014
Q3
Sell
-629
Closed -$18K 1395
2014
Q2
$18K Hold
629
﹤0.01% 917
2014
Q1
$18K Hold
629
﹤0.01% 909
2013
Q4
$17K Hold
629
﹤0.01% 883
2013
Q3
$17K Hold
629
﹤0.01% 843
2013
Q2
$14K Buy
+629
New +$14.2K ﹤0.01% 874

Other funds holding EHC

FineMark National Bank & Trust's EHC Position: Q3 2016 in Review

FineMark National Bank & Trust sold out of Encompass Health (EHC) in Q3 2016, closing a stake of 168 shares — an estimated $5K sold.

FineMark National Bank & Trust first reported a position in EHC in Q2 2013 and held it in 12 quarters. The position peaked at $18K in Q2 2014. 271 funds tracked by Wall St. Rank hold EHC as of Q3 2016.

  • FineMark National Bank & Trust reported no remaining Encompass Health position as of Q3 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 168 Encompass Health shares in Q3 2016, an estimated $5K.
  • FineMark National Bank & Trust first reported a position in Encompass Health in Q2 2013 and held it in 12 quarters.
  • FineMark National Bank & Trust's Encompass Health position peaked at $18K in Q2 2014.
  • 271 funds tracked by Wall St. Rank held Encompass Health as of Q3 2016.

Based on FineMark National Bank & Trust's 13F filing for Q3 2016, filed 10 Nov 2016.